By: James Pitt  Aug. 17, 2018
The Centers for Medicare and Medicaid Services reimburses heart valve procedures based on which of six diagnosis-related groups (DRGs) they fall in. These groups are based on whether there were complications/ comorbidities (CCs) and on whether cardiac catheterization was used.Read more
By: James Pitt  Aug. 16, 2018
When plaque builds up in the arteries that carry blood to the brain, the patient has carotid artery disease. This disease creates a great risk of stroke, because plaque can break off and cause an obstruction in vessels in the brain. Carotid artery disease is involved in 8% of ischemic strokes. Per Weber and Clair 2014, “Carotid artery disease leading to stroke is one [of] the primary causes of serious long-term disability in the United States today.”Read more
By: James Pitt  Aug. 15, 2018
Peripheral artery disease (PAD) is a common condition in which narrowed blood vessels reduce blood flow to the limbs. Calcium buildups on the vessel walls frequently complicate treatment. Rocha-Singh et. al write “The prevalence of VC [vascular calcification] in lower extremity PAD is inadequately defined, but data extrapolated from other vascular beds provide evidence that 30-50% of patients may manifest some degree of VC.”Read more
By: James Pitt  Aug. 10, 2018
Baroreflex activation therapy is an experimental treatment for heart failure with reduced ejection fraction. A device called the BAROSTIM NEO, developed by CVRx, is currently recruiting for clinical trial (NCT02627196), with final results on heart failure morbidity and mortality expected in 2021. Preliminary results as of August 2017 include reduced heart failure hospitalization and reduced blood pressure.Read more
By: James Pitt  Jul. 09, 2018
Hospitals and physicians often struggle with how to evaluate the economic & quality benefits of WCDs. Hospitals & physicians face a number of challenges including:
What should be the appropriate measure that measures the quality & economic benefits of WCDs?
How does one get the data to measure the benefit?
Can we even get the right resources & teams to analyze the data?
By: James Pitt  Jul. 06, 2018
Heart failure can be classified by ejection fraction. In heart failure with reduced ejection fraction (HFrEF, aka LVEF), the left ventricle pumps out an unusually low fraction of the blood that enters it. HFrEF has been a focus of research efforts, because most studies find it is associated with higher mortality than heart failure with preserved ejection fraction (HFpEF).Read more
By: James Pitt  Jun. 22, 2018
According to the Centers for Disease Control, heart failure remains the leading cause of death in the United States for both men and women. Dexur analysts examined rates of heart failure with reduced ejection fraction (HFrEF) at Alabama hospitals with over 1,500 Medicare-eligible inpatient discharges per year. HFrEF is a subtype of heart failure generally associated with worse outcomes than heart failure with preserved ejection fraction. Dexur has previously reported on HFrEF’s effects on coronary bypass patients in Massachusetts and acute myocardial infarction patients in Florida.Read more
By: James Pitt  Jun. 18, 2018
Coronary artery disease (CAD) is the leading cause of death in the US, killing approximately 370,000 people each year. (Coronary heart disease is a synonym). It occurs when plaque builds up in the arteries that feed the heart itself, a condition called coronary atherosclerosis.Read more
By: James Pitt  Jun. 13, 2018
Coronary artery disease is a condition in which plaque reduces blood flow through arteries to the heart. One of the most common treatments is coronary artery bypass grafting (CABG). This is a surgical procedure in which healthy blood vessels are grafted onto the heart to provide an alternate route for blood to flow, bypassing the occluded arteries.Read more